169 related articles for article (PubMed ID: 27114278)
1. Antimicrobial Peptide P60.4Ac-Containing Creams and Gel for Eradication of Methicillin-Resistant Staphylococcus aureus from Cultured Skin and Airway Epithelial Surfaces.
Haisma EM; Göblyös A; Ravensbergen B; Adriaans AE; Cordfunke RA; Schrumpf J; Limpens RW; Schimmel KJ; den Hartigh J; Hiemstra PS; Drijfhout JW; El Ghalbzouri A; Nibbering PH
Antimicrob Agents Chemother; 2016 Jul; 60(7):4063-72. PubMed ID: 27114278
[TBL] [Abstract][Full Text] [Related]
2. Eradication of meticillin-resistant Staphylococcus aureus from human skin by the novel LL-37-derived peptide P10 in four pharmaceutical ointments.
Nibbering PH; Göblyös A; Adriaans AE; Cordfunke RA; Ravensbergen B; Rietveld MH; Zwart S; Commandeur S; van Leeuwen R; Haisma EM; Schimmel KJM; den Hartigh J; Drijfhout JW; Ghalbzouri AE
Int J Antimicrob Agents; 2019 Nov; 54(5):610-618. PubMed ID: 31356860
[TBL] [Abstract][Full Text] [Related]
3. LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalents.
Haisma EM; de Breij A; Chan H; van Dissel JT; Drijfhout JW; Hiemstra PS; El Ghalbzouri A; Nibbering PH
Antimicrob Agents Chemother; 2014 Aug; 58(8):4411-9. PubMed ID: 24841266
[TBL] [Abstract][Full Text] [Related]
4. Development of a nose cream containing the synthetic antimicrobial peptide P60.4Ac for eradication of methicillin-resistant Staphylococcus aureus carriage.
Göblyös A; Schimmel KJ; Valentijn AR; Fathers LM; Cordfunke RA; Chan HL; Oostendorp J; Nibbering PH; Drijfhout JW; Hiemstra PS; Hartigh JD
J Pharm Sci; 2013 Oct; 102(10):3539-44. PubMed ID: 23955373
[TBL] [Abstract][Full Text] [Related]
5. Surface disinfection properties of the combination of an antimicrobial peptide, ranalexin, with an endopeptidase, lysostaphin, against methicillin-resistant Staphylococcus aureus (MRSA).
Desbois AP; Lang S; Gemmell CG; Coote PJ
J Appl Microbiol; 2010 Feb; 108(2):723-30. PubMed ID: 19709343
[TBL] [Abstract][Full Text] [Related]
6. MRSA decolonization of cotton rat nares by a combination treatment comprising lysostaphin and the antimicrobial peptide ranalexin.
Desbois AP; Sattar A; Graham S; Warn PA; Coote PJ
J Antimicrob Chemother; 2013 Nov; 68(11):2569-75. PubMed ID: 23800902
[TBL] [Abstract][Full Text] [Related]
7. Preliminary investigations into developing all-D Omiganan for treating Mupirocin-resistant MRSA skin infections.
Ng SMS; Teo SW; Yong YE; Ng FM; Lau QY; Jureen R; Hill J; Chia CSB
Chem Biol Drug Des; 2017 Dec; 90(6):1155-1160. PubMed ID: 28581672
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of skin and nasal povidone-iodine preparation against mupirocin-resistant methicillin-resistant Staphylococcus aureus and S. aureus within the anterior nares.
Anderson MJ; David ML; Scholz M; Bull SJ; Morse D; Hulse-Stevens M; Peterson ML
Antimicrob Agents Chemother; 2015 May; 59(5):2765-73. PubMed ID: 25733504
[TBL] [Abstract][Full Text] [Related]
9. Designing an ultra-short antibacterial peptide with potent activity against Mupirocin-resistant MRSA.
Arfan G; Ong CYF; Ng SMS; Lau QY; Ng FM; Ong EHQ; Hill J; Chia CSB
Chem Biol Drug Des; 2019 Jan; 93(1):4-11. PubMed ID: 30103288
[TBL] [Abstract][Full Text] [Related]
10. SPS-neutralization in tissue samples for efficacy testing of antimicrobial peptides.
Dijksteel GS; Nibbering PH; Ulrich MMW; Middelkoop E; Boekema BKHL
BMC Infect Dis; 2019 Dec; 19(1):1093. PubMed ID: 31888515
[TBL] [Abstract][Full Text] [Related]
11. Thrombocidin-1-derived antimicrobial peptide TC19 combats superficial multi-drug resistant bacterial wound infections.
Riool M; de Breij A; Kwakman PHS; Schonkeren-Ravensbergen E; de Boer L; Cordfunke RA; Malanovic N; Drijfhout JW; Nibbering PH; Zaat SAJ
Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183282. PubMed ID: 32376222
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of mupirocin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates by phenotypic and genotypic methods].
Us T; Kural M; Yayla B; Kiremitçi A; Cetin E; Akgün Y
Mikrobiyol Bul; 2009 Jul; 43(3):353-64. PubMed ID: 19795610
[TBL] [Abstract][Full Text] [Related]
13. Design and surface immobilization of short anti-biofilm peptides.
Mishra B; Lushnikova T; Golla RM; Wang X; Wang G
Acta Biomater; 2017 Feb; 49():316-328. PubMed ID: 27915018
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates.
Candel FJ; Morales G; Picazo JJ
Rev Esp Quimioter; 2011 Sep; 24(3):127-30. PubMed ID: 21947094
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of antibacterial activity of topical antimicrobials against methicillin-resistant Staphylococcus aureus].
Cui S; Han L; Xiao S; Chen X; Chang Q; Liu Y; Zhang X
Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):21-4. PubMed ID: 24684985
[TBL] [Abstract][Full Text] [Related]
16. Community-genotype strains of methicillin-resistant Staphylococcus aureus with high-level mupirocin resistance in a neonatal intensive care unit.
Park SH; Kim SY; Lee JH; Park C; Lee DG
Early Hum Dev; 2013 Sep; 89(9):661-5. PubMed ID: 23707691
[TBL] [Abstract][Full Text] [Related]
17. TXA497 as a topical antibacterial agent: comparative antistaphylococcal, skin deposition, and skin permeation studies with mupirocin.
Dorrani M; Kaul M; Parhi A; LaVoie EJ; Pilch DS; Michniak-Kohn B
Int J Pharm; 2014 Dec; 476(1-2):199-204. PubMed ID: 25263100
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity and therapeutic efficacy of Fl-P(R)P(R)P(L)-5, a cationic amphiphilic polyproline helix, in a mouse model of staphylococcal skin infection.
Thangamani S; Nepal M; Chmielewski J; Seleem MN
Drug Des Devel Ther; 2015; 9():5749-54. PubMed ID: 26543355
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial peptide Epinecidin-1 promotes complete skin regeneration of methicillin-resistant Staphylococcus aureus-infected burn wounds in a swine model.
Huang HN; Pan CY; Wu HY; Chen JY
Oncotarget; 2017 Mar; 8(13):21067-21080. PubMed ID: 28177877
[TBL] [Abstract][Full Text] [Related]
20. In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
Kanayama S; Ikeda F; Okamoto K; Nakajima A; Matsumoto T; Ishii R; Amano A; Matsuzaki K; Matsumoto S
J Infect Chemother; 2016 Oct; 22(10):720-3. PubMed ID: 27091753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
